Ciphergen Biosystems, Inc.
6611 Dumbarton Circle
Fremont
California
94555
United States
Tel: 510-505-2100
Fax: 510-505-2101
Website: http://www.ciphergen.com/
Email: staffing@ciphergen.com
About Ciphergen Biosystems, Inc.
Corporate OverviewCiphergen Biosystems, Inc. develops, manufactures, and markets ProteinChip(R) Systems that enable protein discovery, characterization and assay development so researchers can gain a better understanding of biological functions at the protein level.
The ProteinChip Biomarker System is a powerful tool that provides a direct approach to understanding the role of proteins in the biology of disease, monitoring of disease progression and the therapeutic effects of drugs.
Pioneering researchers around the world are taking full advantage of Ciphergen's powerful SELDI-based ProteinChip platform to advance clinical proteomics for predictive medicine.
Products and Technology
The Ciphergen ProteinChip® System provides scientists with a versatile, integrated platform for biological research. Biologically important molecules from a variety of sources may be captured and analyzed on our ProteinChip Arrays, using our ProteinChip Readers and user-friendly ProteinChip Software for rapid data analysis. These tools are available through a variety of Ciphergen Partnership Programs.
The ProteinChip® System from Ciphergen Biosystems uses patented SELDI (Surface-Enhanced Laser Desorption/Ionization) ProteinChip technology to rapidly perform the separation, detection and analysis of proteins at the femtomole level directly from biological samples. The ProteinChip System can replace and complement a wide range of traditional analytical methods, which are not only more time consuming, but require specialized scientific expertise. Research that previously required days, weeks or even months can now be accomplished in an afternoon.
Careers
Participate in the proteomics revolution at Ciphergen Biosystems! Our mission is to improve understanding of disease processes through advanced protein technology products and services. Our ProteinChip® System is an integrated and fully supported platform comprising ProteinChip arrays, instrumentation and software. To find out what you can do to be a part of the proteomics revolution, consider these job opportunities.
Last Updated: 04-23-02
78 articles about Ciphergen Biosystems, Inc.
-
Vermillion Completes Name Change From Ciphergen Biosystems, Inc.
8/27/2007
-
Vermillion (Formerly Ciphergen (CIPH) Announces $20.5 Million Private Placement of Common Stock
8/24/2007
-
Ciphergen Biosystems, Inc. Reports Second Quarter 2007 Financial Results and Business Progress
8/14/2007
-
Ciphergen Biosystems, Inc. Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry Patent
7/11/2007
-
Ciphergen Biosystems, Inc. Licenses More Than 25 Patents From Health Discovery Corporation
7/10/2007
-
Health Discovery Corporation Settles Patent Infringement Suit against Ciphergen Biosystems, Inc.
7/6/2007
-
Ciphergen Biosystems, Inc. Announces Results of Annual Meeting
7/6/2007
-
Ciphergen Biosystems, Inc. Announces Issuance of European Patent Covering a Method for Aiding Bladder Cancer Diagnosis
5/30/2007
-
Ciphergen Biosystems, Inc. Reports First Quarter 2007 Financial Results and Business Progress
5/16/2007
-
Ciphergen Biosystems, Inc. Appoints Steve Lundy as Senior Vice President of Sales and Marketing
5/16/2007
-
Ciphergen Biosystems, Inc. to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007
5/14/2007
-
Ciphergen Biosystems, Inc. to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco
5/9/2007
-
Ciphergen Biosystems, Inc. Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer
4/16/2007
-
Ciphergen Biosystems, Inc. Announces Presentation at Upcoming American Association for Cancer Research Annual Meeting
4/11/2007
-
Ciphergen Biosystems, Inc. Presents Data Validating Ovarian Cancer Triage Test at Society of Gynecologic Oncologists Annual Meeting
3/5/2007
-
Ciphergen Biosystems, Inc. Reports Fourth Quarter And Year-End 2006 Financial Results And Provides Milestones For 2007
2/23/2007
-
Ciphergen Biosystems, Inc. To Announce Fourth Quarter And Year End 2006 Financial Results And Host Conference Call On Friday, February 23, 2007
2/20/2007
-
Ciphergen Biosystems, Inc. Initiates Clinical Trial For Ovarian Cancer Triage Test
2/13/2007
-
Ciphergen Biosystems, Inc. To Participate At The Biotechnology Industry Organization (BIO) CEO And Investor Conference
2/9/2007
-
Ciphergen Biosystems, Inc. Announces Publication Of Data Describing Application For Evaluating Patients With Blood Disorder
1/29/2007